Literature DB >> 35304657

Evolution of Support Vector Machine and Regression Modeling in Chemoinformatics and Drug Discovery.

Raquel Rodríguez-Pérez1,2, Jürgen Bajorath3,4.   

Abstract

The support vector machine (SVM) algorithm is one of the most widely used machine learning (ML) methods for predicting active compounds and molecular properties. In chemoinformatics and drug discovery, SVM has been a state-of-the-art ML approach for more than a decade. A unique attribute of SVM is that it operates in feature spaces of increasing dimensionality. Hence, SVM conceptually departs from the paradigm of low dimensionality that applies to many other methods for chemical space navigation. The SVM approach is applicable to compound classification, and ranking, multi-class predictions, and -in algorithmically modified form- regression modeling. In the emerging era of deep learning (DL), SVM retains its relevance as one of the premier ML methods in chemoinformatics, for reasons discussed herein. We describe the SVM methodology including strengths and weaknesses and discuss selected applications that have contributed to the evolution of SVM as a premier approach for compound classification, property predictions, and virtual compound screening.
© 2022. The Author(s).

Entities:  

Keywords:  Compound classification; Machine learning; Property prediction; Regression; Support vector machines

Mesh:

Year:  2022        PMID: 35304657      PMCID: PMC9325859          DOI: 10.1007/s10822-022-00442-9

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   4.179


  36 in total

1.  Virtual screening of selective multitarget kinase inhibitors by combinatorial support vector machines.

Authors:  X H Ma; R Wang; C Y Tan; Y Y Jiang; T Lu; H B Rao; X Y Li; M L Go; B C Low; Y Z Chen
Journal:  Mol Pharm       Date:  2010-08-26       Impact factor: 4.939

2.  Combinatorial support vector machines approach for virtual screening of selective multi-target serotonin reuptake inhibitors from large compound libraries.

Authors:  Z Shi; X H Ma; C Qin; J Jia; Y Y Jiang; C Y Tan; Y Z Chen
Journal:  J Mol Graph Model       Date:  2011-10-05       Impact factor: 2.518

3.  Lead hopping using SVM and 3D pharmacophore fingerprints.

Authors:  Jamal C Saeh; Paul D Lyne; Bryan K Takasaki; David A Cosgrove
Journal:  J Chem Inf Model       Date:  2005 Jul-Aug       Impact factor: 4.956

Review 4.  Support vector machines for drug discovery.

Authors:  Kathrin Heikamp; Jürgen Bajorath
Journal:  Expert Opin Drug Discov       Date:  2013-12-05       Impact factor: 6.098

5.  Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets.

Authors:  Jameed Hussain; Ceara Rea
Journal:  J Chem Inf Model       Date:  2010-03-22       Impact factor: 4.956

Review 6.  How far can virtual screening take us in drug discovery?

Authors:  Supratik Kar; Kunal Roy
Journal:  Expert Opin Drug Discov       Date:  2013-01-21       Impact factor: 6.098

7.  Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.

Authors:  Hao Tang; Xiang S Wang; Xi-Ping Huang; Bryan L Roth; Kyle V Butler; Alan P Kozikowski; Mira Jung; Alexander Tropsha
Journal:  J Chem Inf Model       Date:  2009-02       Impact factor: 4.956

8.  Bayesian models leveraging bioactivity and cytotoxicity information for drug discovery.

Authors:  Sean Ekins; Robert C Reynolds; Hiyun Kim; Mi-Sun Koo; Marilyn Ekonomidis; Meliza Talaue; Steve D Paget; Lisa K Woolhiser; Anne J Lenaerts; Barry A Bunin; Nancy Connell; Joel S Freundlich
Journal:  Chem Biol       Date:  2013-03-21

9.  Protein-ligand interaction prediction: an improved chemogenomics approach.

Authors:  Laurent Jacob; Jean-Philippe Vert
Journal:  Bioinformatics       Date:  2008-08-01       Impact factor: 6.937

10.  Support Vector Machine Classification and Regression Prioritize Different Structural Features for Binary Compound Activity and Potency Value Prediction.

Authors:  Raquel Rodríguez-Pérez; Martin Vogt; Jürgen Bajorath
Journal:  ACS Omega       Date:  2017-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.